Newport Isoprinosine trials
Clinical trials in HIV (human immunodeficiency virus) seropositive asymptomatic patients will begin in Australia and Scandinavia in next several weeks and trials with AIDS-related complex patients will begin in the U.S. in the next two months. The studies will involve approximately 2,000 patients. Newport said it has also submitted a proposal to NIH for the study of Isoprinosine in combination with an antiviral drug in ARC patients.
You may also be interested in...
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.